New Launch6 Dec 2024, 06:47 pm
Venus Remedies Secures Marketing Authorization in Philippines for Pemetrexed 500mg
AI Summary
Venus Remedies Limited has announced the grant of Marketing Authorization for Pemetrexed 500mg, a chemotherapeutic agent used in the treatment of lung cancer and mesothelioma, in the Philippines. This authorization is a significant milestone for the company as it strengthens its presence in the Southeast Asian pharmaceutical market.
Key Highlights
- Venus Remedies secures Marketing Authorization in Philippines for Pemetrexed 500mg
- Pemetrexed 500mg is a chemotherapeutic agent used in the treatment of lung cancer and mesothelioma
- This authorization marks a significant milestone in Venus Remedies' journey to strengthen its presence in the Southeast Asian pharmaceutical market